Fulton Breakefield Broenniman’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255K Buy
2,015
+37
+2% +$4.68K 0.02% 167
2025
Q1
$253K Sell
1,978
-633
-24% -$81K 0.02% 155
2024
Q4
$345K Hold
2,611
0.02% 138
2024
Q3
$380K Sell
2,611
-76
-3% -$11.1K 0.03% 130
2024
Q2
$369K Hold
2,687
0.03% 131
2024
Q1
$369K Hold
2,687
0.03% 132
2023
Q4
$365K Sell
2,687
-28
-1% -$3.8K 0.03% 126
2023
Q3
$332K Buy
2,715
+16
+0.6% +$1.96K 0.03% 134
2023
Q2
$343K Buy
2,699
+12
+0.4% +$1.52K 0.03% 135
2023
Q1
$347K Sell
2,687
-200
-7% -$25.8K 0.03% 131
2022
Q4
$379K Buy
2,887
+1
+0% +$131 0.03% 129
2022
Q3
$338K Hold
2,886
0.03% 127
2022
Q2
$340K Hold
2,886
0.03% 133
2022
Q1
$376K Sell
2,886
-452
-14% -$58.9K 0.03% 122
2021
Q4
$509K Buy
3,338
+452
+16% +$68.9K 0.04% 125
2021
Q3
$467K Sell
2,886
-31
-1% -$5.02K 0.04% 117
2021
Q2
$477K Sell
2,917
-29
-1% -$4.74K 0.04% 126
2021
Q1
$444K Buy
2,946
+612
+26% +$92.2K 0.04% 124
2020
Q4
$354K Sell
2,334
-573
-20% -$86.9K 0.04% 107
2020
Q3
$394K Sell
2,907
-39
-1% -$5.29K 0.04% 126
2020
Q2
$403K Buy
2,946
+200
+7% +$27.4K 0.05% 124
2020
Q1
$296K Sell
2,746
-132
-5% -$14.2K 0.04% 125
2019
Q4
$347K Hold
2,878
0.04% 143
2019
Q3
$286K Buy
+2,878
New +$286K 0.04% 150
2016
Q2
Sell
-31,218
Closed -$2.71M 121
2016
Q1
$2.71M Sell
31,218
-858
-3% -$74.6K 0.59% 62
2015
Q4
$3.62M Sell
32,076
-1,248
-4% -$141K 0.8% 53
2015
Q3
$3.37M Sell
33,324
-1,845
-5% -$187K 0.79% 56
2015
Q2
$4.33M Sell
35,169
-381
-1% -$46.9K 0.95% 49
2015
Q1
$4.07M Buy
35,550
+81
+0.2% +$9.27K 0.91% 49
2014
Q4
$3.59M Sell
35,469
-90
-0.3% -$9.1K 0.79% 53
2014
Q3
$3.24M Buy
35,559
+594
+2% +$54.2K 0.76% 55
2014
Q2
$3M Buy
34,965
+2,409
+7% +$206K 0.73% 54
2014
Q1
$2.57M Buy
+32,556
New +$2.57M 0.66% 56